cro.directory
← Compare landing

Chimera Biotec GmbH vs Crux Biolabs

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryChimera Biotec GmbHCrux Biolabs
SummaryChimera Biotec provides ultra-sensitive GLP/GCP bioanalytical immunoassay support for drug development, including custom assay development, assay transfer, and method validation. Its proprietary Imperacer immuno-PCR technology supports sub-pg/ml sensitivity.Australia-based bioanalytical CRO offering small molecule LC-MS PK, ligand-binding large molecule PK, immunogenicity (ADA), biomarker, and flow cytometry assays for clinical programs. Services are delivered within an ISO/IEC 17025-accredited scope where applicable.
Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Analytical Method Development & Validation
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
Modalities
  • Biologics (Other)
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Vaccine
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Metabolic
  • Infectious Disease
Phases
  • Discovery
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Data not yet provided.
Sourcing modelsData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Bayswater, Bayswater, Victoria, Australia
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Chimera Biotec GmbH alternatives · Crux Biolabs alternatives

Markdown mirror: /compare/chimera-biotec/cruxbiolabs.md